BSIM Therapeutics results published in Amyloid, The Journal

25 July, 2019

Large apresenta%c3%a7%c3%a3o1

Results published in Amyloid, The Journal, show that one of the technologies developed by BSIM Therapeutics stabilizes transthyretin in the cerebrospinal fluid and in the vitreous humor.

Read more here and here.

By continuing to browse the site, you expressly agree that cookies will be stored on your computer to help measure statistics of visits and improve the quality of the contents offered.Learn more